Revenue Estimates Analysis of ReShape Lifesciences Inc.(NASDAQ:RSLS): Snap Inc.(NYSE:SNAP)

0
11

ReShape Lifesciences Inc. (RSLS) will report its next earnings on Nov 14 AMC. The company reported the earnings of $-672/Share in the last quarter where the estimated EPS by analysts was $-250.6/share. The difference between the expected and actual EPS was $-421.4/share, which represents an Earnings surprise of -168.2%.

Many analysts are providing their Estimated Earnings analysis for ReShape Lifesciences Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for ReShape Lifesciences Inc. as 350 Million. According to these analysts, the Low Revenue Estimate for ReShape Lifesciences Inc. is 1.24 Million and the High Revenue Estimate is 1.24 Million. The company had Year Ago Sales of 360 Million.

Some buy side analysts are also providing their Analysis on ReShape Lifesciences Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

ReShape Lifesciences Inc. closed its last trading session at $0.76 with the gain of 0%. The Market Capitalization of the company stands at 440000. The Company has 52-week high of $3756.90 and 52-week low of $0.74. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -47.82% where SMA50 and SMA200 are -76.7% and -99.9% respectively. The Company Touched its 52-Week High on 01/25/18 and 52-Week Low on 12/04/18.

The Relative Volume of the company is 1.05 and Average Volume (3 months) is 1.08 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -101.3%. The Return on Equity (ROE) value stands at -123.4%. While it’s Return on Investment (ROI) value is -41.1%.

While looking at the Stock’s Performance, ReShape Lifesciences Inc. currently shows a Weekly Performance of -9.52%, where Monthly Performance is -71.43%, Quarterly performance is -91.46%, 6 Months performance is -99.86% and yearly performance percentage is -99.97%. Year to Date performance value (YTD perf) value is -99.98%. The Stock currently has a Weekly Volatility of 9.15% and Monthly Volatility of 46.80%.

Snap Inc. (SNAP) will report its next earnings on Oct 25 AMC. The company reported the earnings of $-0.12/Share in the last quarter where the estimated EPS by analysts was $-0.14/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 14.3%.

Many analysts are providing their Estimated Earnings analysis for Snap Inc. and for the current quarter 24 analysts have projected that the stock could give an Average Earnings estimate of $-0.08/share. These analysts have also projected a Low Estimate of $-0.13/share and a High Estimate of $-0.06/share.

In case of Revenue Estimates, 29 analysts have provided their consensus Average Revenue Estimates for Snap Inc. as 374.16 Million. According to these analysts, the Low Revenue Estimate for Snap Inc. is 332.98 Million and the High Revenue Estimate is 392 Million. The company had Year Ago Sales of 285.69 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for SNAP to be 38.5%. They are projecting Next Quarter growth of 35.29%. For the next 5 years, Snap Inc. is expecting Growth of 36.54% per annum, whereas in the past 5 years the growth was 14.75% per annum.

Some buy side analysts are also providing their Analysis on Snap Inc., where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 6 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.67 and Average Volume (3 months) is 24.94 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -45.8%. The Return on Equity (ROE) value stands at -52.6%. While it’s Return on Investment (ROI) value is -102.1%.

While looking at the Stock’s Performance, Snap Inc. currently shows a Weekly Performance of -2.97%, where Monthly Performance is -8.94%, Quarterly performance is -38.58%, 6 Months performance is -52.7% and yearly performance percentage is -54.24%. Year to Date performance value (YTD perf) value is -57.49%. The Stock currently has a Weekly Volatility of 4.27% and Monthly Volatility of 4.92%.

SHARE